ESC 365 - Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom

ESC Premium Access

Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom

Session: Non-troponin biomarkers in acute coronary syndromes

Topic: Biomarkers

Speaker: Doctor K. Sopova (Mannheim, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Kateryna Sopova

University Medical Centre of Mannheim, Mannheim (Germany)

0 follower

4 more presentations in this session

Apoptotic and non-apoptotic circulating microparticles in patients with acute coronary syndromes

Speaker: Doctor A. Antonopoulos (Athens, GR)

Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction

Speaker: Professor C. Garlichs (Flensburg, DE)

HsCRP predicts mortality beyond troponin in 102,337 patients with suspected acute coronary syndrome (CRP-RISK study)

Speaker: Doctor A. Kaura (London, GB)

Circulating levels of ST2 are associated with myocardial injury, left ventricular function and future adverse clinical events in patients with ST-elevation myocardial infarction.

Speaker: Doctor J. Eritsland (Oslo, NO)

Access the full session

Non-troponin biomarkers in acute coronary syndromes

Speakers: Doctor K. Sopova, Doctor A. Antonopoulos, Professor C. Garlichs, Doctor A. Kaura, Doctor J. Eritsland

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources